News & Updates

Show Multimedia Only
Accelerated daratumumab infusion safe, well tolerated in multiple myeloma

Accelerated daratumumab infusion safe, well tolerated in multiple myeloma

29 May 2022

Accelerated administration of daratumumab, an anti-CD3 monoclonal antibody approved for multiple myeloma, is safe and well tolerated when given following at least two standard infusions, suggest the results of a recent study.

29 May 2022